SOAT1 and granuloma annulare: Remarkably, the JAK-STAT specific biological inhibitor, tofacitinib, has a potent effect promoting rebalance of exacerbated immunity among sarcoidosis and granuloma annulare patients reestablishing homeostasis [83].